Osaic Holdings’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.1K | Buy |
564
+307
| +119% | +$6.57K | ﹤0.01% | 5659 |
|
2025
Q1 | $4.66K | Sell |
257
-208
| -45% | -$3.77K | ﹤0.01% | 6128 |
|
2024
Q4 | $11.7K | Sell |
465
-26
| -5% | -$657 | ﹤0.01% | 5623 |
|
2024
Q3 | $16.7K | Sell |
491
-198
| -29% | -$6.73K | ﹤0.01% | 5436 |
|
2024
Q2 | $25.5K | Sell |
689
-71
| -9% | -$2.63K | ﹤0.01% | 5133 |
|
2024
Q1 | $31.9K | Buy |
760
+213
| +39% | +$8.94K | ﹤0.01% | 5035 |
|
2023
Q4 | $21.7K | Sell |
547
-146
| -21% | -$5.79K | ﹤0.01% | 5439 |
|
2023
Q3 | $19.1K | Sell |
693
-117
| -14% | -$3.22K | ﹤0.01% | 5569 |
|
2023
Q2 | $27.5K | Sell |
810
-98
| -11% | -$3.33K | ﹤0.01% | 5337 |
|
2023
Q1 | $32.7K | Sell |
908
-57
| -6% | -$2.05K | ﹤0.01% | 5244 |
|
2022
Q4 | $42K | Sell |
965
-69
| -7% | -$3K | ﹤0.01% | 5051 |
|
2022
Q3 | $29K | Sell |
1,034
-10
| -1% | -$280 | ﹤0.01% | 5302 |
|
2022
Q2 | $28K | Buy |
1,044
+66
| +7% | +$1.77K | ﹤0.01% | 5363 |
|
2022
Q1 | $32K | Buy |
978
+39
| +4% | +$1.28K | ﹤0.01% | 5381 |
|
2021
Q4 | $37K | Buy |
939
+27
| +3% | +$1.06K | ﹤0.01% | 5351 |
|
2021
Q3 | $49K | Sell |
912
-10
| -1% | -$537 | ﹤0.01% | 5116 |
|
2021
Q2 | $31K | Hold |
922
| – | – | ﹤0.01% | 5373 |
|
2021
Q1 | $18K | Sell |
922
-13
| -1% | -$254 | ﹤0.01% | 5520 |
|
2020
Q4 | $16K | Sell |
935
-399
| -30% | -$6.83K | ﹤0.01% | 5240 |
|
2020
Q3 | $20K | Buy |
1,334
+13
| +1% | +$195 | ﹤0.01% | 4882 |
|
2020
Q2 | $17K | Buy |
1,321
+367
| +38% | +$4.72K | ﹤0.01% | 4858 |
|
2020
Q1 | $1K | Buy |
+954
| New | +$1K | ﹤0.01% | 5711 |
|